Document
IPR2018-00943, No. 1080-133 Exhibit - Joi L Dunbar et al, Single and Multiple Dose Pharmacokinetics of Long acting Injectable Naltrexone (P.T.A.B. May. 7, 2019)
Cite Document
IPR2018-00943, No. 1080-133 Exhibit - Joi L Dunbar et al, Single and Multiple Dose Pharmacokinetics of Long acting Injectable Naltrexone (P.T.A.B. May. 7, 2019)
+ More Snippets
Document
VIVITROL, 021897, Letter (Orange Book May. 6, 2021)
Cite Document
VIVITROL, 021897, Letter (Orange Book May. 6, 2021)
+ More Snippets
Document
VIVITROL, 021897, Label (Orange Book Mar. 4, 2021)
Cite Document
VIVITROL, 021897, Label (Orange Book Mar. 4, 2021)
+ More Snippets
Document
VIVITROL, 021897, Letter (Orange Book Mar. 4, 2021)
Cite Document
VIVITROL, 021897, Letter (Orange Book Mar. 4, 2021)
+ More Snippets
Document
IPR2018-00943, No. 1039-34 Exhibit - In hwan Baek et al, Evaluation of the Bioequivalence of Two Brands of Naltrexone 50 mg Tablet in Healthy Volunteers (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1039-34 Exhibit - In hwan Baek et al, Evaluation of the Bioequivalence of Two Brands of Naltrexone 50 mg Tablet in Healthy Volunteers (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1047-56 Exhibit - Food and Drug Administration, FDA PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE MEETING VIVITROL (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1047-56 Exhibit - Food and Drug Administration, FDA PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE MEETING VIVITROL (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1013-13 Exhibit - TN Alim, et al, Tolerability Study of A Depot Form of Naltrexone Substance Abusers (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1013-13 Exhibit - TN Alim, et al, Tolerability Study of A Depot Form of Naltrexone Substance Abusers (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1010-57 Exhibit - Sandra D Comer et al, Depot naltrexone long lasting antagonism of the effects of heroin in humans (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1010-57 Exhibit - Sandra D Comer et al, Depot naltrexone long lasting antagonism of the effects of heroin in humans (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1037-32 Exhibit - Bioequivalence, Center for Drug Evaluation and Research, Application Number (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1037-32 Exhibit - Bioequivalence, Center for Drug Evaluation and Research, Application Number (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1008-8 Exhibit - US Serial Number 11083,167, Amendment After Final, Oct 20, 2010 (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1008-8 Exhibit - US Serial Number 11083,167, Amendment After Final, Oct 20, 2010 (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1050-45 Exhibit - BA Johnson, Naltrexone long acting formulation in the treatment of alcohol dependence (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1050-45 Exhibit - BA Johnson, Naltrexone long acting formulation in the treatment of alcohol dependence (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1056-51 Exhibit - LinkedIn profile of Steve Wright (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1056-51 Exhibit - LinkedIn profile of Steve Wright (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1041-36 Exhibit - Trademark Manual of Examining Procedure TMEP (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1041-36 Exhibit - Trademark Manual of Examining Procedure TMEP (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1012-12 Exhibit - CN Chiang et al, Clinical Evaluation of A Naltrexone Sustained Release Preparation (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1012-12 Exhibit - CN Chiang et al, Clinical Evaluation of A Naltrexone Sustained Release Preparation (P.T.A.B. Apr. 20, 2018)
+ More Snippets
Document
IPR2018-00943, No. 1018-16 Exhibit - US Patent No 6,264,987 (P.T.A.B. Apr. 20, 2018)
Cite Document
IPR2018-00943, No. 1018-16 Exhibit - US Patent No 6,264,987 (P.T.A.B. Apr. 20, 2018)
+ More Snippets